bpc-157 upregulates growth hormone receptor vs. TB-500, CJC-1295, and More: Comparative Insights in Peptide Research BPC-157: Benefits, Dosing & Side

You are not making a cocktail

The mechanism targets tissue repair rather than acid suppression, so it addresses a different part of the healing pathway

Dosing depends entirely on the form: the DAC version is dosed roughly once or twice weekly because of its extended half-life, while the non-DAC version (Mod GRF 1-29) is dosed more frequently, often before bed or post-workout, to align with natural GH pulses

They are route-specific doses, not convertible ones: 100 mg drawn into a syringe is 20 to 30 times the intended exposure

Retatrutide: Phase 2 data showed A1c reductions of 1.5-2.0%, with the glucagon component adding complexity to blood sugar management